VTGN logo

VistaGen Therapeutics (VTGN) Accounts Payable

Annual Accounts Payable

$1.55 M
-$926.00 K-37.44%

March 31, 2024


Summary


Performance

VTGN Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTGNbalance sheetmetrics:

Quarterly Accounts Payable

$715.00 K
-$494.00 K-40.86%

September 30, 2024


Summary


Performance

VTGN Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVTGNbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

VTGN Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-37.4%0.0%
3 y3 years+84.5%0.0%
5 y5 years+46.6%0.0%

VTGN Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-43.9%+84.5%-86.9%at low
5 y5-year-43.9%+84.5%-86.9%at low
alltimeall time-43.9%>+9999.0%-86.9%>+9999.0%

VistaGen Therapeutics Accounts Payable History

DateAnnualQuarterly
Sep 2024
-
$715.00 K(-40.9%)
Jun 2024
-
$1.21 M(-21.8%)
Mar 2024
$1.55 M(-37.4%)
$1.55 M(-10.9%)
Dec 2023
-
$1.74 M(+33.1%)
Sep 2023
-
$1.30 M(-19.6%)
Jun 2023
-
$1.62 M(-34.4%)
Mar 2023
$2.47 M(-10.4%)
$2.47 M(+54.7%)
Dec 2022
-
$1.60 M(-45.9%)
Sep 2022
-
$2.96 M(-46.0%)
Jun 2022
-
$5.47 M(+98.4%)
Mar 2022
$2.76 M(+229.1%)
$2.76 M(+41.6%)
Dec 2021
-
$1.95 M(-26.7%)
Sep 2021
-
$2.66 M(+14.8%)
Jun 2021
-
$2.32 M(+176.3%)
Mar 2021
$838.30 K(-54.4%)
$838.30 K(+8.0%)
Dec 2020
-
$776.40 K(-34.0%)
Sep 2020
-
$1.18 M(-10.0%)
Jun 2020
-
$1.31 M(-28.8%)
Mar 2020
$1.84 M(+74.1%)
$1.84 M(+14.0%)
Dec 2019
-
$1.61 M(+11.1%)
Sep 2019
-
$1.45 M(+55.2%)
Jun 2019
-
$933.90 K(-11.5%)
Mar 2019
$1.05 M(-11.8%)
$1.05 M(-2.9%)
Dec 2018
-
$1.09 M(+84.2%)
Sep 2018
-
$590.10 K(-6.3%)
Jun 2018
-
$629.50 K(-47.4%)
Mar 2018
$1.20 M(+37.9%)
$1.20 M(+134.8%)
Dec 2017
-
$509.30 K(-55.8%)
Sep 2017
-
$1.15 M(+82.1%)
Jun 2017
-
$632.00 K(-27.1%)
Mar 2017
$867.30 K
$867.30 K(-0.8%)
Dec 2016
-
$874.40 K(-6.0%)
DateAnnualQuarterly
Sep 2016
-
$930.20 K(+0.0%)
Jun 2016
-
$930.10 K(-0.6%)
Mar 2016
$936.00 K(-58.4%)
$936.00 K(-14.7%)
Dec 2015
-
$1.10 M(-1.1%)
Sep 2015
-
$1.11 M(-28.4%)
Jun 2015
-
$1.55 M(-31.2%)
Mar 2015
$2.25 M(-7.9%)
$2.25 M(-6.8%)
Dec 2014
-
$2.42 M(+7.5%)
Sep 2014
-
$2.25 M(+18.2%)
Jun 2014
-
$1.90 M(-22.2%)
Mar 2014
$2.44 M(+80.5%)
$2.44 M(+8.3%)
Dec 2013
-
$2.26 M(+13.7%)
Sep 2013
-
$1.98 M(+12.8%)
Jun 2013
-
$1.76 M(+29.9%)
Mar 2013
$1.35 M(-22.7%)
$1.35 M(+8.1%)
Dec 2012
-
$1.25 M(-15.0%)
Sep 2012
-
$1.47 M(-42.5%)
Jun 2012
-
$2.56 M(+46.4%)
Mar 2012
$1.75 M(>+9900.0%)
$1.75 M(+68.1%)
Dec 2011
-
$1.04 M(-16.0%)
Sep 2011
-
$1.24 M(+31.5%)
Jun 2011
-
$943.20 K(>+9900.0%)
Mar 2011
-
$6200.00(+129.6%)
Dec 2010
$2700.00(+170.0%)
$2700.00(-6.9%)
Sep 2010
-
$2900.00(+190.0%)
Jun 2010
-
$1000.00(-73.0%)
Mar 2010
-
$3700.00(+270.0%)
Dec 2009
$1000.00(-54.5%)
$1000.00(-54.5%)
Sep 2009
-
$2200.00(+120.0%)
Jun 2009
-
$1000.00(-54.5%)
Dec 2008
$2200.00
$2200.00(-31.3%)
Jun 2008
-
$3200.00(+45.5%)
Mar 2008
-
$2200.00

FAQ

  • What is VistaGen Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for VistaGen Therapeutics?
  • What is VistaGen Therapeutics annual accounts payable year-on-year change?
  • What is VistaGen Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for VistaGen Therapeutics?
  • What is VistaGen Therapeutics quarterly accounts payable year-on-year change?

What is VistaGen Therapeutics annual accounts payable?

The current annual accounts payable of VTGN is $1.55 M

What is the all time high annual accounts payable for VistaGen Therapeutics?

VistaGen Therapeutics all-time high annual accounts payable is $2.76 M

What is VistaGen Therapeutics annual accounts payable year-on-year change?

Over the past year, VTGN annual accounts payable has changed by -$926.00 K (-37.44%)

What is VistaGen Therapeutics quarterly accounts payable?

The current quarterly accounts payable of VTGN is $715.00 K

What is the all time high quarterly accounts payable for VistaGen Therapeutics?

VistaGen Therapeutics all-time high quarterly accounts payable is $5.47 M

What is VistaGen Therapeutics quarterly accounts payable year-on-year change?

Over the past year, VTGN quarterly accounts payable has changed by $0.00 (0.00%)